We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Image: Extracellular vesicles offer a noninvasive way to access meaningful brain signals from a small blood sample (Image Credit: Shutterstock)

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases

NanoSomiX and Beckman Coulter Diagnostics will collaborate on next-generation extracellular vesicle-based immunoassays for neurodegenerative diseases. More...
23 Jul 2026
Image: The second‑generation assay detects all four Ebola viruses known to cause human disease: Bundibugyo, Zaire, Sudan, and Taï Forest (Image Credit: Adobe Stock)

New Rapid Ebola Antigen Test Detects Infection at Point of Care

A new rapid antigen test enables 30-minute point-of-care detection of four Ebola viruses in patients and the deceased. More...
23 Jul 2026
Image: Visual Abstract (Seemesh Bhaskar et al., Point of care molecular cancer diagnostics, Lab on a Chip, 2026. DOI: 10.1039/d5lc01014d)

Point-of-Care Molecular Technology Promises Transformative Shift in Oncology

A new review highlights how POC molecular diagnostic technology is transforming cancer detection and treatment monitoring. More...
23 Jul 2026
Image: Workflow of 19 F NMR–based serum amino acid profiling and data analysis. Serum samples collected from CRC patients were subjected to fluorine-labeling–based amino acid detection followed by 19 F NMR spectroscopy. Quantified amino acid data were processed using ratio-based normalization and multivariate analyses to characterize stage-specific metabolic patterns and construct machine learning models for prognostic risk prediction. (Photo courtesy of KAIST)

Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis

A single preoperative blood sample may improve recurrence or metastasis prediction in colorectal cancer patients. More...
23 Jul 2026
Image: FirstGene delivers fetal chromosome, fetal single-gene, patient carrier, and fetal RhD screening in one integrated report (Photo courtesy of Myriad Genetics)

New Test Delivers Four Prenatal Genetic Screens from One Blood Sample

Myriad Genetics has launched FirstGene, a single-sample prenatal test that performs four genetic screens simultaneously. More...
22 Jul 2026
Image Credit: Adobe Stock

Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk

New findings profile gene variants and map protein defects, improving genetic test interpretation for inherited heart muscle disease. More...
22 Jul 2026
Image: The acquisition brings together Personalis’ MRD technology with Tempus’ commercial scale, multimodal data, and AI platform to advance cancer monitoring, deepen insights, and accelerate growth

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal

Tempus AI has entered into a definitive agreement to acquire Personalis, expanding its capabilities in MRD testing and cancer monitoring. More...
22 Jul 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Copyright © 2000-2026 Globetech Media. All rights reserved.